Basispoints Podcast - Kari Firestone: What Peter Lynch Taught Her About Stocks
Google at 26x with profitability double the entire US media industry it displaced. Amazon at 21x. Kari Firestone says bubble talk is a category error - the 1999 dot-coms had no earnings and mostly no longer exist.
“Portfolio manager stock” is Kari’s term for Tesla: you are not buying a business, you are buying Elon’s judgment about what it becomes. She will not hold it at scale. All three hosts pick Nvidia in a 10-year hold.
Tesla’s profits fell from $12.9B to $3.8B over four years with no revenue growth. The stock premium is entirely optionality and Elon - Amit let his shares get called away and has no re-entry plan.
Biotech’s Moderna scar tissue is four years old and fading. FDA deregulation could shorten Phase 3 timelines. Kari - who covered biotech at Fidelity from 1992 - is actively researching names. The window before the narrative arrives is the one she is studying.
The Valuation Question
Google trades at roughly 26x earnings. Amazon trades at roughly 21x. Those multiples are cheaper than Walmart and Costco.
Kari Firestone has 40-plus years behind that observation. She ran money alongside Peter Lynch on the Fidelity Magellan Fund starting in 1983, co-founded Aureus Asset Management (over $8 billion, concentrated 35-name large-cap growth), and has seen enough cycles to know what a real bubble looks like. The Mag 7 is not one.
The dot-com companies had no profits, mostly no revenue, and most do not exist today. Today’s AI infrastructure play is built on companies generating hundreds of billions in earnings, funding AI capex from their own free cash flow Kari @ 17:03.
Google’s profitability is double the entire combined media industry it displaced. At 26x, you are paying for a business with no analog for its earnings quality Kari @ 21:48.
“I’m not at a point where I would say that these stocks are overpriced just because of who they are.” Kari @ 22:36
The genuine bubble she identifies: electric utilities at 50x marketed as AI plays. Utilities cannot raise prices without government approval - 50x for a business that cannot grow its top line is a real bubble. The Mag 7 at 21-26x is not.
The Ceiling Nobody Talks About
Strong fundamentals do not automatically translate to price appreciation. The historical buyers of “Halo stocks” are value-oriented institutional buyers who care what they pay. When multiples stretch beyond their comfort, they sell - creating a natural ceiling on multiple expansion even when earnings grow Kari @ 31:19.
Returns from here come from earnings growth, not from the multiple going higher. Big tech can deliver high-teens earnings growth. Most sectors cannot.
Nvidia or Tesla
All three - Kari, Steve, and Amit - pick Nvidia in a 10-year hold.
Kari calls Tesla a “portfolio manager stock.” The problem is not Elon’s track record - the technology is genius. The problem is that buying Tesla means buying Elon’s judgment about what it becomes: EVs, robotics, AI, or something none of them can predict. That is not a definable business Kari @ 43:37.
“I do not like buying the portfolio manager. I don’t want to put my money in something that could be a very different looking thing that I didn’t expect five years from now.” Kari @ 43:37
For Nvidia: the chip business is definable, it is the premier chip company with no high-end competitor, and she can model it. Tesla’s profitability fell from roughly $12.9B to $3.8B over three to four years with no revenue growth. The stock premium is all potential and Elon.
Cross-source tension: other podcasts from the same week have Dan Ives putting 80%+ odds on a SpaceX-Tesla merger by 2027. Bulls and Kari are not arguing about the same company - that is the “portfolio manager stock” problem in real time.
How She Picks Stocks
Two recent positions show the method.
Wabtec (WAB): Aureus built the position when Kari identified a railroad capex cycle. Five things converged - expanding markets, fewer overseas competitors, low raw material costs, unused pricing power, and an entry multiple of 12x earnings. The model showed 12-15% earnings growth and multiple expansion from cheap to fair Kari @ 33:14. The stock is now expensive - she would trim.
Deckers/Hoka (DECK): Hoka had a hot cycle, Nike took share back, the stock fell below market multiples. Kari is a runner. She tested the redesigned shoes personally, identified underpenetrated overseas markets, and confirmed limited tariff exposure. Below-market multiple, product renewal, overseas upside - she bought Kari @ 35:35.
The framework: identify the cycle or product renewal, build a model that shows the earnings path, buy at a multiple discount to the market.
“He would say that building a good portfolio was like walking on a rocky beach - you are going to turn over every single stone or shell. And underneath one out of every 500, there is going to be a gem. But you have to keep looking.” Kari @ 7:49
The April 30th Call
On April 30th, Kari went on CNBC’s Halftime Report and called the bottom. She recommended buying Meta and Microsoft - Iran’s economic position was deteriorating, the conflict had to resolve, and the stocks had fallen “so far so fast” that the downside looked irrational Kari @ 30:18.
She was right. The market has since recovered to all-time highs with oil still above $85. Steve bought that day with $2,500. Amit was buying Nvidia and Microsoft on X throughout the drawdown.
Where She Looks Next
Biotech has been a dead zone since 2022. Moderna peaked near $500, then fell roughly 94% - leaving scar tissue across the sector even for investors who were never in Moderna Kari @ 37:43. Four years in, Kari thinks that overhang is fading.
She is also watching the FDA. Her conviction: the current administration will streamline drug approvals, shortening timelines for companies with clean Phase 3 data. That catalyst is not in the sector multiple Kari @ 39:23. She has done work on Novo Nordisk (down roughly 70%) without yet buying.
The last watch signal: AI drug discovery will eventually produce its first commercially available drug. The window before that narrative shift is where she is working.
Alpha Takeaway
Google at 26x with profitability double the US media industry is not a dot-com repeat. Returns follow earnings growth, not multiple expansion - Mag 7 can deliver it.
“Portfolio manager stock” is the Nvidia/Tesla distinction that matters. You cannot model a business that can become anything; that uncertainty caps institutional ownership regardless of fundamentals.
Biotech FDA deregulation is a catalyst four years of Moderna scar tissue has not priced. The multiple is cheap relative to the optionality on the table.
This newsletter is for informational purposes only and does not constitute investment advice. All views attributed to named speakers reflect their own opinions, not Podcast Alpha’s. The author may hold positions in securities mentioned. Do your own research before making any investment decision.